Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Adrenoleukodystrophy (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 2)
Angina Pectoris (Phase 3)
beta-Thalassemia (Phase 1/Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Breast Neoplasms (Phase 1)
Cardiomyopathy, Dilated (Phase 2)
Cardiovascular Diseases (Phase 1)
Chest Pain (Phase 1)
Chimerism (Phase 2)
Chronic Limb-Threatening Ischemia (Phase 1/Phase 2)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
COVID-19 (Phase 1)
Crohn Disease (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Diabetic Retinopathy (Phase 1)
Fanconi Anemia (Phase 1)
Heart Diseases (Phase 3)
Heart Failure (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 1)
Immune System Diseases (Phase 2)
Kidney Transplantation (Phase 2/Phase 3)
Leukemia (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukodystrophy, Metachromatic (Phase 2)
Liver Diseases (Phase 1/Phase 2)
Lupus Erythematosus, Systemic (Phase 2)
Lymphoma (Phase 2)
Lysosomal Storage Diseases (Phase 2)
Macular Degeneration (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Pancytopenia (Phase 1)
Peripheral Arterial Disease (Phase 1/Phase 2)
Peripheral Vascular Diseases (Phase 1/Phase 2)
Plasmacytoma (Phase 2)
Primary Immunodeficiency Diseases (Phase 2)
Retinal Diseases (Phase 1)
Retinal Vein Occlusion (Phase 1/Phase 2)
Retinitis Pigmentosa (Phase 1)
Severe Combined Immunodeficiency (Phase 1)
X-Linked Combined Immunodeficiency Diseases (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue